BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32533592)

  • 1. Pharmacist's perspective on HCQ treatment of COVID-19.
    Wang YL; Wang SH; Yang AY
    Kaohsiung J Med Sci; 2020 Aug; 36(8):660. PubMed ID: 32533592
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of Acute Hemeolytic Anaemia (AHA).
    Dar SA; Wahid M; Haque S; Almalki SS; Akhter N
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7923-7924. PubMed ID: 32767316
    [No Abstract]   [Full Text] [Related]  

  • 3. Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going.
    Parra-Lara LG; Martínez-Arboleda JJ; Rosso F
    J Glob Antimicrob Resist; 2020 Sep; 22():680-684. PubMed ID: 32622008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxychloroquine and azithromycin as a treatment of COVID-19.
    Fanin A; Calegari J; Beverina A; Tiraboschi S;
    Intern Emerg Med; 2020 Aug; 15(5):841-843. PubMed ID: 32474851
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research.
    Frigerio M
    Int J Cardiol; 2020 Oct; 316():285-286. PubMed ID: 32473921
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroxychloroquine-azithromycin for COVID-19 - Warranted or dangerous?
    Popescu CP; Fischer PR
    Travel Med Infect Dis; 2020; 35():101764. PubMed ID: 32485391
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend.
    Hor CP; Hussin N; Nalliah S; Ooi WT; Tang XY; Zachariah S; Jugindar Singh GPS; Abdul Rani R; Perumal K; Cheah WK
    J Infect; 2020 Aug; 81(2):e117-e119. PubMed ID: 32474031
    [No Abstract]   [Full Text] [Related]  

  • 8. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
    Lebeaux D; Revest M
    Travel Med Infect Dis; 2020; 36():101819. PubMed ID: 32629139
    [No Abstract]   [Full Text] [Related]  

  • 9. Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center.
    Pothen L; Yildiz H; De Greef J; Penaloza A; Beauloye C; Belkhir L; Yombi JC
    Travel Med Infect Dis; 2020; 36():101788. PubMed ID: 32540396
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation.
    Bonow RO; Hernandez AF; Turakhia M
    JAMA Cardiol; 2020 Sep; 5(9):986-987. PubMed ID: 32936259
    [No Abstract]   [Full Text] [Related]  

  • 11. Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
    Bonny A; Talle MA; Ngantcha M; Tayebjee MH
    Travel Med Infect Dis; 2020; 37():101861. PubMed ID: 32889105
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
    Maisonnasse P; Guedj J; Contreras V; Behillil S; Solas C; Marlin R; Naninck T; Pizzorno A; Lemaitre J; Gonçalves A; Kahlaoui N; Terrier O; Fang RHT; Enouf V; Dereuddre-Bosquet N; Brisebarre A; Touret F; Chapon C; Hoen B; Lina B; Calatrava MR; van der Werf S; de Lamballerie X; Le Grand R
    Nature; 2020 Sep; 585(7826):584-587. PubMed ID: 32698191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Not Available].
    Farfán-López M; Espinoza-Culupú A
    Rev Peru Med Exp Salud Publica; 2020; 37(2):383-384. PubMed ID: 32876237
    [No Abstract]   [Full Text] [Related]  

  • 14. Review of: "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949.
    Rosendaal FR
    Int J Antimicrob Agents; 2020 Jul; 56(1):106063. PubMed ID: 32674928
    [No Abstract]   [Full Text] [Related]  

  • 15. Problems with the analysis in "Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19".
    Atkinson JG
    Int J Infect Dis; 2020 Oct; 99():37. PubMed ID: 32738492
    [No Abstract]   [Full Text] [Related]  

  • 16. Flexibilization of Science, Cognitive Biases, and the COVID-19 Pandemic.
    Oliveira J E Silva L; Vidor MV; Zarpellon de Araújo V; Bellolio F
    Mayo Clin Proc; 2020 Sep; 95(9):1842-1844. PubMed ID: 32861327
    [No Abstract]   [Full Text] [Related]  

  • 17. Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19.
    Mazzitelli M; Davoli C; Scaglione V; Fusco P; La Gamba V; Matera G; Trecarichi EM; Torti C
    Travel Med Infect Dis; 2020; 37():101826. PubMed ID: 32739472
    [No Abstract]   [Full Text] [Related]  

  • 18. Comment on Arshad et al.: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19.
    Varisco TJ; Johnson ML; Thornton D
    Int J Infect Dis; 2020 Oct; 99():373. PubMed ID: 32771630
    [No Abstract]   [Full Text] [Related]  

  • 19. Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19.
    Rosenberg ES; Holtgrave DR; Udo T
    Int J Infect Dis; 2020 Oct; 99():38-39. PubMed ID: 32738483
    [No Abstract]   [Full Text] [Related]  

  • 20. The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials.
    Malviya A
    Int J Infect Dis; 2020 Oct; 99():310-311. PubMed ID: 32738490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.